Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2020 09:04 ET | Source: Intrommune Therapeutics

Survey Confirms Physician Interest in Peanut Allergy Immunotherapy

New York, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and other...
September 16, 2019 14:25 ET | Source: Intrommune Therapeutics

Intrommune Therapeutics Supports Outcome of FDA Allergenic Product Advisory Committee Vote

New York, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biotechnology company developing a patient-friendly immunotherapy platform for the treatment of peanut and...